收涨100%!这家0收入创新药企要火?

中国基金报
24 Jul

在港股创新药的大行情下,目前0收入且亏损的维立志博获得港股市场追捧。  利弗莫尔证券暗盘交易显示,截至收盘,将于7月25日(周五)在港股挂牌上市的维立志博以70.05港元报收,较35港元的招股价上涨100.14%;每手100股,不计手续费,每手赚3505港元。   维立志博是一家尚未盈利的创新药公司,拟全球发售3205.44万股(假设未行使调整权及超配权),招股价区间为31.60港元至35.00...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10